ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Lung transplantation"

  • 2019 American Transplant Congress

    Waitlisted for Lung Transplant and the Role of Patient Travel Distance: A National Cohort Study

    W. Tsuang, S. Arrigain, R. Lopez, M. Snair, K. McCurry, M. Budev, J. Schold

    Cleveland Clinic, Cleveland, OH

    *Purpose: Among patients waitlisted at the 75 lung transplant centers in the United States, the role of travel distance on waitlist outcomes is unknown. We…
  • 2019 American Transplant Congress

    Progress Using Genetically Engineered Pigs for Lung Xenotransplantation

    L. Burdorf1, C. Laird2, S. Sendil2, T. Zhang2, D. Parsell2, I. Tatarov2, B. Cerel1, Z. Abady1, S. Pratts1, C. J. Phelps3, D. L. Ayares3, A. M. Azimzadeh1, R. N. Pierson III1

    1Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, 2Surgery, University of MD, Baltimore, MD, 3Revivicor, Blacksburg, VA

    *Purpose: CRISPR/Cas9 gene editing techniques facilitate generation of pigs with multiple genetic modifications. We report results associated with multiple mechanistically targeted gene knock-outs and transgenes,…
  • 2019 American Transplant Congress

    Differential Impact of Donor and Recipient Age on Post-Lung Transplantation Outcomes

    K. Patel1, C. Li1, C. Wallace1, J. Kilkenny1, D. P. Allen1, S. Nadig1, M. Goddard2, C. Krieg1, C. Atkinson1

    1Surgery, Medical University of South Carolina, Charleston, SC, 2Pathology, Royal Papworth Hospital NHS Trust, C, SC

    *Purpose: Donor and recipient age at the time of lung transplantation (LTx) have been implicated in poor patient outcomes. The underlying mechanisms driving these effects…
  • 2019 American Transplant Congress

    Patient-Reported Self-Management in Lung Transplant Candidates

    C. C. Kennedy1, M. Budev2, S. Chandrashekaran3, D. Erasmus4, E. D. Lease5, D. Levine6, K. Thompson1, E. Stevens1, R. Benzo1

    1Mayo Clinic, Rochester, MN, 2Cleveland Clinic, Cleveland, OH, 3University of Florida- Gainesville, Gainesville, FL, 4Mayo Clinic, Jacksonville, FL, 5University of Washington, Seattle, WA, 6University of Texas Health Science Center San Antonio, San Antonio, TX

    *Purpose: Pre-transplant risk factors are strongly associated with worse post-transplant survival (e.g. frailty); however, effective pre-transplant strategies to improve outcomes are lacking. We hypothesize that…
  • 2019 American Transplant Congress

    Opioid Use Policies and Practices in Liver Transplant and Lung Transplant Candidates: A Comparison of National Surveys

    H. Bruschwein1, V. Andersen1, H. Patel2, S. S. Rogal3, J. N. Fleming4

    1University of Virginia, Charlottesville, VA, 2University of North Carolina, Chapel Hill, NC, 3University of Pittsburgh, Pittsburgh, PA, 4Medical University of South Carolina, Charleston, SC

    *Purpose: Pre-transplant opioid use has been associated with increased risk of morbidity and mortality. Alternatively, opioid substitution therapy (OST) has been proven to be a…
  • 2019 American Transplant Congress

    A Metagene Signature of Lymphocytic Bronchitis Following Lung Transplantation

    J. R. Greenland1, P. Wang2, J. J. Brotman2, R. Ahuja1, T. A. Chong2, M. Kleinhenz2, L. E. Leard2, J. A. Golden2, S. R. Hays2, J. P. Singer2, J. Kukreja3, N. Y. Greenland4, Z. Lasik4, P. Blanc1

    1Medicine, VA Health Care System, San Francisco, CA, 2Medicine, University of California, San Francisco, CA, 3Surgery, University of California, San Francisco, CA, 4Pathology, University of California, San Francisco, CA

    *Purpose: Lymphocytic bronchitis (LB) precedes chronic lung allograft dysfunction (CLAD). Peri-vascular (A-grade) and peri-bronchiolar (B-grade) lymphocytic inflammation are traditional markers of acute cellular rejection. The…
  • 2019 American Transplant Congress

    Exosomes Isolated from Human Lung Transplant Recipients Diagnosed with Bronchiolitis obliterans Syndrome are Unique in Their Ability to Induce IL-6 via Rab27A Signaling Pathway

    M. Rahman, M. Sharma, S. Angara, M. Smith, R. Bremner, T. Mohanakumar

    Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ

    *Purpose: Rab27, a member of the Rab subfamily of GTPases, has the ability to induce exosome secretion. Exosomes are small membrane vesicles (40-150nm) that regulate…
  • 2019 American Transplant Congress

    Lung Allocation Score Should Be Implemented in China

    C. Ju, Q. Lian, B. Wei, X. Xu, R. Chen, J. He

    State Key Lab of the Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, China

    *Purpose: Lung transplantation (LTx) is an effective treatment for patients with end stage of respiratory disease. Two of the major candidates are patients with chronic…
  • 2019 American Transplant Congress

    Unfavorable Donor after Cardiac Death Characteristics in Lung Transplantation: An Analysis of the UNOS Registry

    A. Y. Choi1, O. K. Jawitz2, V. Raman2, Y. Barac2, M. S. Mulvihill2, C. Moore2, M. G. Hartwig2

    1Duke University School of Medicine, Durham, NC, 2Department of Surgery, Duke University Medical Center, Durham, NC

    *Purpose: Despite growing evidence that donation after circulatory death (DCD) lung transplants have comparable survival outcomes and primary graft dysfunction rates to donation after brain…
  • 2019 American Transplant Congress

    Transplanting Thoracic Organs From Hcv Donors To Uninfected Patients: Evaluation Of Lung Allografts

    Y. Lo1, R. F. Padera1, H. R. Mallidi2, H. J. Goldberg3, S. K. Singh2, A. Coppolino, III4, L. R. Baden5, A. E. Woolley5

    1Pathology, Brigham and Womens Hospital, Boston, MA, 2Cardiac and Thoracic Surgery, Brigham and Womens Hospital, Boston, MA, 3Pulmonary, Brigham and Womens Hospital, Boston, MA, 4Thoracic Surgery, Brigham and Womens Hospital, Boston, MA, 5Infectious Diseases, Brigham and Womens Hospital, Boston, MA

    *Purpose: Prior to the development of direct acting antiviral (DAA) therapy for hepatitis C virus (HCV), there was concern that patients who received lungs from…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 42
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences